Orbimed Advisors LLC Syndax Pharmaceuticals Inc Transaction History

Orbimed Advisors LLC

$4.44 Billion
Q1 2024

A detailed history of Orbimed Advisors LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Orbimed Advisors LLC holds 1,749,000 shares of SNDX stock, worth $33.7 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

1,749,000

Previous 1,749,000 -0.0%

Holding current value

$33.7 Million

Previous $37.8 Million 10.14%

% of portfolio

0.94%

Previous 0.93%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $5.3 Million - $10.1 Million	465,000 Added 36.21%	1,749,000 $37.8 Million
Q3 2023 Nov 14, 2023	SELL	$14.52 - $21.77 $18.1 Million - $27.1 Million	-1,246,240 Reduced 49.25%	1,284,000 $18.6 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $15.8 Million - $18.3 Million	818,565 Added 47.82%	2,530,240 $53 Million
Q1 2023 May 15, 2023	SELL	$20.66 - $28.98 $6.09 Million - $8.54 Million	-294,825 Reduced 14.69%	1,711,675 $36.2 Million
Q3 2022 Nov 14, 2022	SELL	$18.51 - $24.79 $5.86 Million - $7.85 Million	-316,800 Reduced 13.64%	2,006,500 $48.2 Million

Q2 2022 Aug 15, 2022	BUY	$13.64 - $19.48 $2.25 Million - $3.21 Million	165,000 Added 7.64%	2,323,300 $44.7 Million
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $2.63 Million - $3.92 Million	177,000 Added 8.93%	2,158,300 $37.5 Million
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $27.3 Million - $40.2 Million	1,790,700 Added 939.51%	1,981,300 $43.4 Million
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $2.64 Million - $3.77 Million	190,600 New	190,600 $3.64 Million
Q1 2021 May 17, 2021	SELL	$19.28 - $24.59 $22.6 Million - $28.8 Million	-1,170,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $1.16 Million - $2.03 Million	76,800 Added 7.02%	1,170,900 $26 Million
Q2 2020 Aug 14, 2020	BUY	$8.94 - $20.98 $7.19 Million - $16.9 Million	804,100 Added 277.28%	1,094,100 $16.2 Million
Q1 2020 May 15, 2020	BUY	$6.65 - $12.03 $518,700 - $938,340	78,000 Added 36.79%	290,000 $3.18 Million
Q4 2018 Feb 14, 2019	SELL	$3.6 - $8.42 $810,000 - $1.89 Million	-225,000 Reduced 51.49%	212,000 $943,000
Q3 2017 Nov 14, 2017	BUY	$10.9 - $12.73 $4.76 Million - $5.56 Million	437,000	437,000 $5.11 Million

Others Institutions Holding SNDX

# of Institutions

195

Shares Held

90M

Call Options Held

353K

Put Options Held

207K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $1.09B
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account

Orbimed Advisors LLC Syndax Pharmaceuticals Inc Transaction History